NeuBase Therapeutics, Inc. Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NeuBase Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NeuBase Therapeutics, Inc. for March 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.41 | 100 | 341 | 878,254 | 878.2 K to 878.3 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.44 | 100 | 344 | 878,154 | 878.1 K to 878.2 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.46 | 200 | 692 | 878,054 | 877.9 K to 878.1 K (+0.02 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.49 | 100 | 349 | 877,854 | 877.8 K to 877.9 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.50 | 100 | 350 | 877,754 | 877.7 K to 877.8 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.55 | 100 | 355 | 877,654 | 877.6 K to 877.7 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.57 | 100 | 357 | 877,554 | 877.5 K to 877.6 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.58 | 100 | 358 | 877,454 | 877.4 K to 877.5 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.59 | 100 | 359 | 877,354 | 877.3 K to 877.4 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.60 | 400 | 1,440 | 877,254 | 876.9 K to 877.3 K (+0.05 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.61 | 300 | 1,083 | 876,854 | 876.6 K to 876.9 K (+0.03 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.63 | 2,200 | 7,986 | 876,554 | 874.4 K to 876.6 K (+0.25 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.64 | 200 | 728 | 874,354 | 874.2 K to 874.4 K (+0.02 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.65 | 300 | 1,095 | 874,154 | 873.9 K to 874.2 K (+0.03 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.66 | 327 | 1,197 | 873,854 | 873.5 K to 873.9 K (+0.04 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.70 | 1,523 | 5,635 | 873,527 | 872 K to 873.5 K (+0.17 %) |